AMMONIA N-13 - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ammonia n-13 and what is the scope of freedom to operate?
Ammonia n-13
is the generic ingredient in one branded drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Hlth 414, Central Radiopharm, Decatur, Essential Isotopes, Feinstein, Gen Hosp, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Methodist, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Nukemed, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Ucla Biomedical, Ucsf Rodiopharm, Univ Alahama Birm, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Wisconsin, Wa Univ Sch Med, and Wisconsin, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.Twenty suppliers are listed for this compound.
Summary for AMMONIA N-13
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 30 |
NDAs: | 31 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 103 |
Patent Applications: | 1,728 |
What excipients (inactive ingredients) are in AMMONIA N-13? | AMMONIA N-13 excipients list |
DailyMed Link: | AMMONIA N-13 at DailyMed |
Recent Clinical Trials for AMMONIA N-13
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Khyber Medical College, Peshawar | Phase 4 |
Cairo University | Phase 3 |
CBmed Ges.m.b.H. | Phase 4 |
Pharmacology for AMMONIA N-13
Drug Class | Radioactive Diagnostic Agent |
Mechanism of Action | Radiopharmaceutical Activity |
US Patents and Regulatory Information for AMMONIA N-13
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Methodist | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 215083-001 | Jul 9, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Mips Crf | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204535-001 | Nov 20, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sofie | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 203543-001 | Dec 14, 2012 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.